A B-cell receptor-related gene signature predicts response to ibrutinib treatment in mantle cell lymphoma cell lines

被引：4
|
作者：
D'Agaro, Tiziana [1 ]
Zucchetto, Antonella [1 ]
Vit, Filippo [1 ,2 ]
Bittolo, Tamara [1 ]
Tissino, Erika [1 ]
Rossi, Francesca Maria [1 ]
Degan, Massimo [1 ]
Zaja, Francesco [3 ]
Bulian, Pietro [1 ]
Dal Bo, Michele [1 ]
Ferrero, Simone [4 ,5 ]
Ladetto, Marco [4 ,6 ]
Zamo, Alberto [7 ]
Gattei, Valter [1 ]
Bomben, Riccardo [1 ]
机构：
[1] IRCCS, Ctr Riferimento Oncol Aviano CRO, Clin & Expt Oncohematol Unit, Aviano, Italy
[2] Univ Trieste, Dept Life Sci, Trieste, Italy
[3] Univ Trieste, Maggiore Gen Hosp, Dept Internal Med & Haematol, Trieste, Italy
[4] Univ Torino, Dept Mol Biotechnol & Hlth Sci, Hematol Div 1, Turin, Italy
[5] AOU Citta Salute & Sci Torino Univ Hosp, Hematol Div 1, Turin, Italy
[6] Azienda Osped Nazl SS Antonio Biagio & Cesare, SC Ematol, Alessandria, Italy
[7] Univ Torino, Dept Oncol, Turin, Italy
来源：
HAEMATOLOGICA | 2019年 / 104卷 / 09期
关键词：
RESISTANCE;
D O I：
10.3324/haematol.2018.212811
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
    Wilson, Wyndham H.
    Young, Ryan M.
    Schmitz, Roland
    Yang, Yandan
    Pittaluga, Stefania
    Wright, George
    Lih, Chih-Jian
    Williams, P. Mickey
    Shaffer, Arthur L.
    Gerecitano, John
    de Vos, Sven
    Goy, Andre
    Kenkre, Vaishalee P.
    Barr, Paul M.
    Blum, Kristie A.
    Shustov, Andrei
    Advani, Ranjana
    Fowler, Nathan H.
    Vose, Julie M.
    Elstrom, Rebecca L.
    Habermann, Thomas M.
    Barrientos, Jacqueline C.
    McGreivy, Jesse
    Fardis, Maria
    Chang, Betty Y.
    Clow, Fong
    Munneke, Brian
    Moussa, Davina
    Beaupre, Darrin M.
    Staudt, Louis M.
    NATURE MEDICINE, 2015, 21 (08) : 922 - 926
  • [32] Ibrutinib-related atrial fibrillation in patients with mantle cell lymphoma
    Lee, Hun Ju
    Dai, Chihara
    Wang, Michael
    Mouhayar, Elie
    Kim, Peter
    LEUKEMIA & LYMPHOMA, 2016, 57 (12) : 2914 - 2916
  • [33] Mechanism of action of Ibrutinib in mantle cell lymphoma
    Sun, Zhijian
    Zhou, Dongping
    Wei, Min
    Luo, Lusong
    CANCER RESEARCH, 2014, 74 (19)
  • [34] The B-Cell Receptor Is Required for Optimal Viability, Growth, and Chemotherapy Resistance of Diffuse Large B-Cell Lymphoma Cell Lines of the Germinal Center B-Cell Subtype
    Havranek, Ondrej
    Koehrer, Stefan
    Comer, Justin M.
    Wang, Zhiqiang
    Xu, Jingda
    Ghosh, Dipanjan
    Shinners, Nicholas
    Sun, Luhong
    Ma, Wencai
    Burger, Jan A.
    Davis, R. Eric
    BLOOD, 2014, 124 (21)
  • [35] Lymphoma Microenvironment Signature Predicts Clinical Outcomes in Diffuse Large B-Cell Lymphoma Patients
    Miyawaki, Kohta
    Sugio, Takeshi
    Kato, Koji
    Sasaki, Kensuke
    Miyoshi, Hiroaki
    Aster, Jon C.
    Kuo, Frank C.
    Ohshima, Koichi
    Maeda, Takahiro
    Akashi, Koichi
    BLOOD, 2017, 130
  • [36] Phase I/II Clinical Trial of Ibrutinib and Buparlisib in Relapsed/Refractory Diffuse Large B-Cell Lymphoma, Mantle Cell Lymphoma, and Follicular Lymphoma
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (08) : 17 - 18
  • [37] Pathogenic role of B-cell receptor signaling and canonical NF-κB activation in mantle cell lymphoma
    Saba, Nakhle S.
    Liu, Delong
    Herman, Sarah E. M.
    Underbayev, Chingiz
    Tian, Xin
    Behrend, David
    Weniger, Marc A.
    Skarzynski, Martin
    Gyamfi, Jennifer
    Fontan, Lorena
    Melnick, Ari
    Grant, Cliona
    Roschewski, Mark
    Navarro, Alba
    Bea, Silvia
    Pittaluga, Stefania
    Dunleavy, Kieron
    Wilson, Wyndham H.
    Wiestner, Adrian
    BLOOD, 2016, 128 (01) : 82 - 92
  • [38] Combining Ibrutinib with Chk1 Inhibitors Synergistically Targets Mantle Cell Lymphoma Cell Lines
    Valentina Restelli
    Monica Lupi
    Micaela Vagni
    Rosaria Chilà
    Francesco Bertoni
    Giovanna Damia
    Laura Carrassa
    Targeted Oncology, 2018, 13 : 235 - 245
  • [39] Evaluation of Idelalisib with B-Cell Receptor or Orthogonal Pathway Inhibitors in Diffuse Large B-Cell Lymphoma Cell Lines in Vitro and In Vivo
    Meadows, Sarah
    Yahiaoui, Anella
    Sorensen, Rick
    Cui, Zhi-Hua
    Brockett, Robert
    Keegan, Kathleen S.
    Tannheimer, Stacey
    BLOOD, 2016, 128 (22)
  • [40] Combining Ibrutinib with Chk1 Inhibitors Synergistically Targets Mantle Cell Lymphoma Cell Lines
    Restelli, Valentina
    Lupi, Monica
    Vagni, Micaela
    Chila, Rosaria
    Bertoni, Francesco
    Damia, Giovanna
    Carrassa, Laura
    TARGETED ONCOLOGY, 2018, 13 (02) : 235 - 245
12345